[Featured Stock] Bacsell Bio Rises Over 8%... Impact of Obtaining 'Cell Culture Patent'
[Asia Economy Reporter Park Jihwan] Baxel Bio is showing a strong gain of over 8% following the news of obtaining a cell culture patent.
According to the Korea Exchange on the 12th, as of 10:13 AM, Baxel Bio is trading at 102,000 KRW, up 8.74% (8,200 KRW) compared to the previous trading day.
Baxel Bio announced after the market closed on the 8th that it had obtained a patent related to "culture auxiliary cells expressing OX40L and a method for culturing natural killer cells using the same." After closing higher on the 9th, the stock showed a decline for two days until the 11th, then resumed a sharp rise.
Hot Picks Today
Cerebras Soars 70% on IPO Debut: Is Nvidia's Reign Ending as a New AI Semiconductor Power Emerges?
- Is It the “8,000-Point Curse”? KOSPI Drops to 7,400 After Brief Surge; KOSDAQ Falls 5%
- "Multi-Million Won Bonuses, Life Is Sweet"—Even Employee Reactions... SK hynix Overtakes Samsung to Claim No. 1 Spot
- "Gave in to the Momentary Temptation": Japanese Police Official Dismissed After Stealing 100 Million Won Next to Body
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
The company stated, "With this invention, it is expected that therapeutic efficiency and efficacy can be dramatically improved in various immune cell therapy fields using natural killer cells."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
